Beyond Blood Thinners: The Unseen Cardiovascular Effects of Anticoagulant Therapy
A new narrative review in Cardiovascular Research explores the pleiotropic effects of anticoagulants, revealing their significant impact on vascular pathology and cardiac function beyond their primary role in preventing thrombosis. The article examines distinctions between different classes of anticoagulants, highlighting how some agents influence cardiac remodeling, endothelial function, and inflammatory pathways. This review synthesizes growing evidence that these drugs have broader cardiovascular implications, which could affect long-term patient outcomes in conditions like heart failure, atrial fibrillation, and coronary artery disease.
Study Significance: For cardiologists and cardiovascular researchers, this review underscores the need to consider the extended pharmacodynamic profile of anticoagulants when managing complex patients. Understanding these pleiotropic mechanisms could refine risk-benefit assessments, particularly for patients with concurrent heart failure or valvular disease, and guide the development of next-generation targeted therapies. It shifts the clinical perspective from viewing these drugs solely as antithrombotic agents to recognizing them as modulators of broader cardiovascular pathophysiology.
Source →Stay curious. Stay informed — with Science Briefing.
Always double check the original article for accuracy.